This page shows the latest Heart news and features for those working in and with pharma, biotech and healthcare.
Hypertrophic cardiomyopathy (HCM) is a chronic and progressive disease which causes excessive contraction of the heart muscles and reduces the ability of the left ventricle to fill. ... In both obstructive or non-obstructive HCM patients, physical
The consequences of this build-up can range from episodes of pain and impaired peripheral sensation to end-organ failure, particularly in the kidneys but also of the heart and the
Side effects from this treatment can cause complications such as organ damage, osteoporosis and problems with the heart, liver and endocrine system resulting in reduced life expectancy. ... I hope with all my heart that one day this serious disease will
That growth was led by an increase in revenue for AZ’s heart failure treatment Farxiga (dapagliflozin), which saw a 27% increase in 2020 to $1.96bn.
Post-marketing study shows increased risk of serious heart-related problems and cancer with Xeljanz. ... The results from the post-market study showed that there was an increased risk of serious heart-related problems and cancer associated with Xeljanz
risk of cardiovascular events such as heart attacks and strokes,” said Steven Ketchum, senior vice president, president of R&D and chief scientific officer of Amarin.
More from news
Approximately 66 fully matching, plus 1,413 partially matching documents found.
And there’s no going back. So if you’re planning to engage heart experts at the ESC Congress later this year, remember this: video can thrill the cardio tsar – but
Patient support programmes have great potential to reduce health inequalities – but only if they’re developed with that goal at their heart,” said Fiona Hammond.
Now new technologies are driving a cultural shift in clinical research, putting the patient experience at the heart of the process. ... Wearable devices worn by patients during trials is one component of this new approach, allowing clinicians to track
The project is initially connecting four of London’s premier teaching hospitals, offering AI services to accelerate work in areas such as cancer, heart failure and neurodegenerative disease, and will expand
We have data- driven self-diagnosis through wearable devices which can monitor people’s vitals such as their blood pressure, oxygen levels or heart rate.
More from intelligence
Approximately 1 fully matching, plus 235 partially matching documents found.
People are my passion and I know that human, personal connections are at the heart of Ashfield Engage’s services – I’m looking forward to sharing this passion with our clients
It’s not every day you get to be a part of, and help build, a new kind of health agency – one with a passion for creativity at its heart and
I’m very pleased to join our team in the UK. We have a deep-rooted presence here at the heart of the UK life sciences industry and I look forward
This includes Pfizer and the American Heart Association. The last addition is Judi Kennedy, who has also joined as a senior vice president.
He said: “Having worked across health and not for profit, it is hugely exciting to join 11, which puts these issues at the heart of everything they do.
More from appointments
Approximately 1 fully matching, plus 36 partially matching documents found.
Addressing these questions early in the process, the strategy puts the patient and HCP perspective at the heart of the communication and enables identification of the modes of communication most likely
Although often dismissed as a result of physiological differences between the sexes, including the lack of the protective effects of oestrogen contributing to heart disease in males, male health isn’t ... 5. Many of the most common health conditions
A shared commitment to measuring impact is also at the heart of the partnership. ... digital solutions like artificial intelligence (AI) will be increasingly at the heart of our work over the next two or three years.”.
technology, AI, and deep-learning-enabled diagnostics for remote monitoring of congestive heart failure, chronic diseases, and COVID-19.
very heart of what motivates me.
More from PMHub
Approximately 5 fully matching, plus 261 partially matching documents found.
Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in...